APA (7th ed.) Citation

Shuai, Y., Ma, Z., Ju, J., Li, C., Bai, X., Yue, J., . . . Qian, H. (2025). The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD. Apoptosis: An International Journal on Programmed Cell Death, 30(1), 226-238. https://doi.org/10.1007/s10495-024-02037-1

Chicago Style (17th ed.) Citation

Shuai, You, Zhonghua Ma, Jie Ju, Chunxiao Li, Xiaorong Bai, Jian Yue, Xue Wang, Peng Yuan, and Haili Qian. "The N6-methyladenosine Writer METTL3 Promotes Breast Cancer Progression Through YTHDF2-dependent Posttranscriptional Silencing of GSDMD." Apoptosis: An International Journal on Programmed Cell Death 30, no. 1 (2025): 226-238. https://doi.org/10.1007/s10495-024-02037-1.

MLA (9th ed.) Citation

Shuai, You, et al. "The N6-methyladenosine Writer METTL3 Promotes Breast Cancer Progression Through YTHDF2-dependent Posttranscriptional Silencing of GSDMD." Apoptosis: An International Journal on Programmed Cell Death, vol. 30, no. 1, 2025, pp. 226-238, https://doi.org/10.1007/s10495-024-02037-1.